The past few years have seen business and technology leaders grapple with one crisis after another. The COVID-19 pandemic was just the start; since then businesses have faced supply chain challenges, the impact of war in Ukraine and the subsequent energy crisis, soaring interest rates and rocketing inflation levels. Whilst the nature of uncertainty has shifted in this time, uncertainty has been the single constant. And one thing is for sure, uncertainty is here for the foreseeable future.
Many business and technology leaders say they struggle to keep up with the rapid pace of change that has become the new norm. To move first and pivot fast, organisations can no longer rely on traditional approaches to planning and organisational design. For businesses to succeed in this high-cost operating environment, leaders must embrace a disruption strategy and mindset to meet uncertainty head-on!
AGENDA:
08:45 Welcome and Introductions
08:50 Fireside Chat
Caroline Boyd, Head of Research and Strategic Development, Chief Disruptor
Mark Parr, Global Director of Information Technology, HFW
David Venter, VP CH Separation, GlaxoSmithKline
09.05 Virtual Roundtable Discussion:
- What are the qualities that leaders will need to succeed in uncertain times?
- Unlocking the power of your data to enable you to plan and move forward decisively
- How can an agile approach enable competitive advantage during unpredictable times
- Exploring the most effective planning model for anticipating and responding to business disruption
- How can disruptive technologies help organisations to grow, even in challenging and unpredictable times?
09.45 Close
Moderator:
Caroline Boyd, Head of Research and Strategic Development, Chief Disruptor
Hear from:
Mark Parr, Global Director of IT, HFW
Mark has a strong pedigree of delivering information systems and technology solutions across the globe. He is a seasoned executive with over 30 years’ experience providing strategy, governance and thought leadership across technology environments and information security disciplines. Mark's broad understanding of technology enables him to navigate the most complex issues and drive consensus to deliver tangible business results.
David Venter, VP CH Separation, GlaxoSmithKline
Accountable for separating the Consumer Healthcare division from GSK into a separately listed company, for all business Processes and Systems (Technology). This separation required the successful listing of two great companies in July 2022, across 80+ countries, 25+ manufacturing sites and R&D plus, 180+ level 2 business processes along with the underlying applications, infrastructure, cyber security and data.
